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Abstract
Introduction: Congenital transmission (CT) of Trypanosoma cruzi has led to globalization of Chagas disease and its growing relevance 
as a public health problem. Although the occurrence of CT has been associated with several factors, its mechanisms are still unknown. 
This study aimed to analyze the geographical and familiar variables of mothers and their association with CT of Chagas disease in a 
population living in non-endemic areas of Argentina for the last decades. Methods: We developed a retrospective cohort study in a 
sample of 2120 mother-child pairs who attended three reference centers in the cities of Buenos Aires, Santa Fe, and Salta between 
2002 and 2015. Results: The highest CT rates were observed in children born to Argentinean mothers (10.7%) and in children born to 
mothers from Buenos Aires (11.7%). Considering the areas of origin of the mothers, those from areas of null-low risk for vector-borne 
infection had higher CT rates than those from areas of medium-high risk (11.1% vs 8.2%). We also observed a significant intra-familiar 
“cluster effect,” with CT rates of 35.9% in children with an infected sibling, compared to 8.2% in children without infected siblings 
(RR=4.4 95% CI 2.3-8.4). Conclusions: The associations observed suggest a higher CT rate in children born to mothers who acquired 
the infection congenitally, with familiar antecedents, and from areas without the presence of vectors. These observations are considered 
new epidemiological evidence about Chagas disease in a contemporary urban population, which may contribute to the study of CT and 
may also be an interesting finding for healthcare professionals.
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INTRODUCTION
According to the estimations of the World Health Organization, 
infection by Trypanosoma cruzi, the etiological agent of Chagas 
disease (CD), affects over 6–8 million people worldwide, 5.5 million 
of whom live in Latin America1,2. Argentina is the country with the 
largest number of persons infected with CD, and annually, there 
are over 1500 congenitally infected newborns1.
Since vector-borne and transfusional transmissions have been 
reduced, congenital transmission (CT) has become the main route 
of generation of new cases of CD in several countries and, thus, 
is considered an important matter of public health. Moreover, 
because of CT and migrations, CD is now observed in urban areas 
and regions known to have no presence of the CD vectors in all 
continents2-4.
The mechanisms involved in CT are still unknown, and its 
occurrence cannot be predicted. Nevertheless, several studies have 
observed the interactions between the following different factors 
that may contribute to the mechanisms of CT: (i) parasitological 
aspects, (ii) the maternal immune system, (iii) placental physiology, 
and (iv) the fetal immune system, determined genetically and by 
environmental interactions5,6.
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Different regions of Latin America and the world present different 
rates of CT, a fact associated with the prevalence of diverse T. cruzi 
discrete typing units (DTUs), named TcI to TcVI7. A recent study, for 
example, has found that both Argentina and Mexico present similar 
CT rates (approximately 6.5%) and that mothers of both countries 
are predominantly infected by non-TcI T. cruzi8, presumably TcV. At 
the same time, in Brazil, where TcII and TcVI are the predominant 
DTUs in the domestic cycle, the rate of CT is approximately 1%9. 
Studies conducted in Chile, Bolivia, and Argentina have shown that 
parasites in mothers and their children are of the same DTU, with 
similar prevalent DTU in the general population10-12. Burgos et al.12 
observed no differences between the genotypes of mothers with 
infected children and those of mothers with non-infected children. 
In an experimental study with placental explants and two strains of 
DTUs, TcII and TcVI, Medina et al.13 found that the latter had more 
infective capacity and pathogenicity than the former.
Regarding the parasitemia levels, several studies have shown 
a higher CT rate in women with higher levels of parasitemia than 
women with lower levels of parasitemia15-18, postulating this as the 
principal risk factor. Additionally, various studies have shown that 
trypanocidal treatment before pregnancy drastically reduces the 
occurrence of CT, which may be explained by a reduction in the 
parasitic load in the peripheral blood19-23. Additionally, according to 
Howard et al.’s23 meta-analysis, the CT rate in non-endemic countries 
is approximately 2%, whereas in endemic countries, it is between 4% 
and 5%. It has been suggested that these higher CT rates in endemic 
countries might be due to higher parasitic loads as a possible result 
of multiple maternal reinfections24,25. However, a study conducted 
in the City of Santa Cruz de la Sierra in Bolivia found that women 
who had never been exposed to the vector had a CT rate of 16.1% 
in comparison to 9.0% in women who had lived in houses with the 
presence of vectors26. The study also found that the former had higher 
parasitic loads than the latter. Similar findings were obtained in a 
study with women residing in Santa Fe, Argentina27. The authors of 
these studies hypothesize that reinfections in rural areas could activate 
the immune response with the consequent control of parasitemia.
Other studies have shown the importance of the immune system 
in the control of parasitemia and how higher CT rates are associated 
with deficiencies in gamma interferon and certain interleukins 
involved in cellular immunity17,28.
Additionally, some researchers have observed the occurrence 
of a “cluster effect” of a higher CT rate through generations of 
the same family and from a mother to several of her children26-30. 
However, these observations were limited considering the small 
sample size in this study.
In the present study, we focused on some maternal characteristics, 
such as their geographical origin and family history, to analyze their 
association with CT of CD in a contemporary population in an 
urban area of Argentina.
METHODS
Our study was conducted on a retrospective cohort on a 
secondary database of 2120 children and their mothers chronically 
infected with T. cruzi who were living in urban areas of Argentina, 
in both non-endemic and endemic regions under control of vector 
transmission. The database was constructed from records of 
three reference centers: the Instituto Nacional de Parasitología 
(INP) (n=1854), the Centro de Diagnóstico e Investigación en 
Endemoepidemias (CeNDIE) (n=41) in the City of Buenos Aires 
(CABA) (most cases of CeNDIE were from studies performed in 
Salta Province), and the Centro de Investigaciones sobre Endemias 
Nacionales (CIEN) (n=225) in the City of Santa Fe. Records were 
obtained from mothers and their children who attended to the 
mentioned centers for controls of congenital CD or who participated 
in particular projects in the past. The information in the records 
was obtained by physicians or trained personnel. Mothers who 
received trypanocidal treatment prior to pregnancy were excluded. 
All available patients who had completed the diagnostic follow-
up (approximately 70%) were included in the database. A case 
of congenital infection was considered when children with no 
exposure to vectors had positive parasitological tests or two reactive 
serological tests after 10 months of age, which were performed at 
the centers mentioned. We analyzed the association between the 
infection in the child and the following maternal variables: age 
at delivery, country and province of birth, risk of vector-borne 
transmission (VR) in the place of birth, place of current residence, 
infection of the mother (i.e., infection of the maternal grandmother 
of the child), and other children infected (brother or sister of the 
child). The VR variable was generated considering the year of 
birth of the mother and the categorization of the place of birth 
mentioned in the literature and programs of vectorial control32-34. 
The category of null VR included non-endemic areas, the category 
of low VR included endemic areas with certification of interruption 
of vector-borne transmission after 1970, and the categories of 
high and medium VR included areas of high or medium historical 
endemicity, without certification of interruption of vector-borne 
transmission after 1970.
Regarding the continuous variables, we calculated the central 
tendency parameters (interquartile ranges, median, mean) for 
infected and non-infected groups and performed Student’s t-test 
to analyze for significant differences. Regarding the categorical 
variables, we calculated the frequencies according to groups of 
infection and performed chi-squared or Fisher’s exact tests as 
necessary. Relative risks (RRs) of congenital infection with their 
confidence intervals (CIs) were calculated for variables that showed 
significant differences between groups. The significance level was 
set at 0.05. Analyses were performed using the Stata 11 software.
Ethical considerations. The databases used for this study were 
secondary data without any personal identification of contact 
information, and each case had an identification code previously 
assigned. The protocol was approved by the scientific committee 
of the institution in charged to conduct the study.
RESULTS
Out of the 2120 children included in the study, 90% were born 
between 2002 and 2015 and lived mainly in the CABA (19.5%) 
and Province of Buenos Aires (PBA, 72.8%), the main metropolitan 
areas of Argentina. Congenital infection with T. cruzi was confirmed 
in 9%  (192/2120) of children. Maternal age at delivery was 
28.9±6.6 years in average, with a normal distribution and a range 
of 14.8–48.8 years. There was no significant difference in the age 
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Source: Own elaboration. Notes: No CT: Pair without congenital transmission; CT: Pair with congenital transmission.
FIGURE 1: Maternal age at delivery, in groups according to maternal country of 
origin and congenital infection of children. Source: Own elaboration. Notes: No 
CT: Pair without congenital transmission; CT: Pair with congenital transmission.
of mothers with infected and non-infected children (Student’s t-test, 
p=0.7389), and the distribution of ages in groups of nationalities 
was also similar (Figure 1). Regarding the country of birth, 60.2% 
of the mothers were born in Argentina, 29.1% in Bolivia, 10.3% in 
Paraguay, and 0.6% in other countries. The CT rate of children born 
to Argentinean mothers was higher (10.7%) than that of children born 
to mothers from other countries (chi-squared test, p=0.003, Table 1). 
In children born to Argentinean mothers, the risk of being infected 
was 50% higher than in children born to Bolivian mothers (RR=1.5; 
95% CI, 1.1–2.1) and approximately twofold higher than that in 
children born to Paraguayan mothers (RR=2.1; 95% CI, 1.2–3.9).
Argentinean women were born in 20 of the 24 provinces, mainly 
in PBA (29.4%), Chaco (14.6%), CABA (14.4%), and Santiago 
del Estero (9.8%) (Annex Table 1). The proportion of infected 
children born to mothers from Buenos Aires (from both PBA and 
CABA) was higher than 10%, followed by 8.1% of children born 
to mothers from Chaco and 4.0% of children born to mothers 
from Santiago del Estero (Table 1). The difference in the CT rate 
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between these groups was not statistically significant (chi-squared 
test, p=0.063). Considering the stratification by VR, we observed 
a higher frequency of cases of CT in the stratum of low-null VR, 
with a rate of 11.1%, which was statistically different from the 
stratum of medium-high VR (chi-squared test, p=0.033, Table 1).
Regarding familiar antecedents, 56% of the mothers (1179/2106) 
did not know the state of infection of their own mother, and of those 
that knew it, 49.3% answered affirmatively. The CT rate in the 
children with an infected grandmother was significantly higher 
than that in those whose grandmother was not infected (13.8% vs 
7.23%, p=0.001). In a subgroup of mother-child pairs (n=198), 
information on infection of siblings was available. In the group of 
infected children (n=34), 67.6% had one or more infected siblings, 
while in the group of non-infected children (n=164), this proportion 
was 25.0%. The CT rate in children with a precedent of an infected 
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sibling (35.9%) was significantly different from that in those without 
an infected sibling (8.2%) (chi-squared test, p=0.000). This implies that 
children with an infected sibling have four times higher risk of infection 
than those without an infected sibling (RR=4.4; 95% CI, 2.3–8.4).
DISCUSSION
This study focused on a contemporary population of Buenos 
Aires, the main metropolitan area of Argentina, which is an urban 
vector-free area, where CD is not perceived as existing or as a 
relevant issue by healthcare professionals and by different levels 
of policy-makers. We observed that women with CD were born 
in almost all provinces of Argentina, not only in those endemic 
for the vector or rural areas but also in urban and non-endemic 
areas. Almost half of the Argentinean women studied were born in 
Buenos Aires (CABA and PBA); hence, we can assume that they 
had acquired the infection by CT and did not have adequate access 
to the diagnosis and treatment of CD. This may also be associated to 
the luck of awareness of the mother’s state of infection mentioned 
in more than half of the women. This should be considered by 
healthcare teams to eliminate the belief that people with CD are 
only those migrating from rural or historically endemic localities, 
particularly in Argentina to reinforce the need to accomplish the 
guidelines of universal control for CD in pregnant women and 
children born to infected mothers.
The CT rate observed in Argentinean women was higher than 
that in Bolivian and Paraguayan women, a result consistent with 
results of other studies16,23,35. In cases of differences in CT rates, 
these may be explained by the diversity in the age of the newborn 
and diagnostic techniques used. The results of this study contribute 
to the hypothesis that differential CT rates are associated with the 
prevalence of different parasite lineages.
Several researchers have mentioned that the principal risk factor 
for CT is the high parasitemia in pregnant women14-17. We may 
suppose that those women are from endemic areas, with higher 
probability of reinfection by vector exposure, and younger women 
with more recent infections. When we analyzed the mother’s age 
at delivery in relation to CT, we found no significant differences, 
in contrast to that previously reported by other authors17,31. When 
we considered the variables of maternal geographical origin, we 
surprisingly found that children born to women from non-endemic 
areas had the highest CT rates. This was observed mainly in children 
born to Argentinean women and in children born to women from 
Buenos Aires (CABA and PBA). Furthermore, when considering 
the variable of VR, the group with the highest CT rate was that of 
low-null VR. As mentioned above, considering the country of origin 
of the mother, we also found higher CT rate in children born to 
Argentinean women, half of whom were from non-endemic areas. 
Although Paraguay and Bolivia have substantially improved vector 
control, this process is recent and hence, women included in this 
study were considered to be from medium-high VR areas.
These observations may lead to the hypothesis that at ecological 
level, women originally from endemic areas (resident in non-
endemic areas) would not have higher parasitemia and therefore 
no higher risk for CT. This hypothesis is consistent to what was 
observed by Rendell et al. in Bolivia26, where women who had 
been exposed to the vector showed lower parasitic load in the 
peripheral blood and lower CT rate than women who had not been 
exposed. Another possibility is that exposure to a higher load of 
parasites, reinfection, or the vector-mediated infection would have 
led to a process of adaptation, equilibrium, and protection to the 
placental passage of the parasite. Since this study did not include 
data on parasitological exams, further studies should confirm 
this epidemiological observation and this hypothesis. However, 
excluding the assumption of a higher parasitemia caused by vector-
borne reinfection, it is striking that women born in areas of medium-
high VR showed a lower CT rate and not, in any case, the same rate 
as women from areas of low-null VR. Women born and raised in 
non-endemic areas would have the particularity of having acquired 
the infection exclusively by congenital route (or exceptionally 
by contaminated transfusion), whereas those from endemic areas 
would have acquired the infection by both the congenital and 
vectorial routes of transmission. The studies of Sanchez-Negrette 
et al. conducted in Salta29 and Suasnábar et al. in Santa Fe27, both in 
Argentina, also presented similar observations, showing that women 
from rural areas of high endemicity had lower CT rates than women 
from urban areas not exposed to the vector. Sanchez-Negrette et al. 
proposed the occurrence of a “cluster effect,” which suggests that 
women from areas of lower VR may be infected by strains with a 
greater “capacity for congenital transmission,” thus giving place to 
transmission from one generation to another or to several children. 
This would be a selection process leading to the prevalence of 
“more transmissible” strains. This selection process would be more 
evident in urban areas where no vector-borne infections take place, 
and thus, is avoided the presence of other strains that at population 
level may result in lower CT rates.  Medina et al.13 conducted an in 
vitro study in which they used a strain isolated from a patient with 
congenital infection and found that it had greater virulence for CT 
compared with another strain of a different genotype. This is the first 
relevant evidence of the hypothesis of “more transmissible strains” 
selected through generational CT. In our study, we also observed 
a clear association between familiar history and CT. Women who 
confirmed infection in their mother had higher CT in their children, 
showing more frequency of persistence through generations when 
mediated by the congenital route of transmission. Moreover, the 
antecedent of infection in another sibling had a significantly strong 
association with the CT rate, implying an increase in risk from 8% 
to 36%. In socio-sanitary terms, this dynamics is noteworthy and 
requires that once a case is detected proactive interventions with 
a familiar approach are assumed, to assure diagnosis and early 
treatment of other cases of CD.
Several studies have shown the relevance of immune factors in 
the parasite-host equilibrium and in the modulation of parasitemia 
levels6,17,28  and the passage or infection of the placenta13,36,37, which 
largely determines the occurrence of CT. These immunological 
characteristics would be shared at the family level6,38 and contribute 
to the multifactorial network that determines the “cluster effect” 
proposed by Sanchez-Negrette et al.28, which we observed in 
epidemiological terms in this study.
Another noteworthy observation was the low CT rate in women 
from Santiago del Estero, a province with historically high levels 
of endemicity. There are no previous records of such difference 
in CT rates between the provinces of Argentina, even comparing 
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with provinces as Chaco, which has a similar level of endemicity. 
This observation could lead to the hypothesis of differences in 
the circulating strains or other biological, environmental, and 
social characteristics of the population, which would contribute to 
attenuation in the virulence of the parasite13,36,37 or to a development 
of an equilibrium with the parasite in women, which would prevent 
the transmission during pregnancy. Another hypothesis is related 
to the administration of trypanocidal treatment through campaigns 
in this province during the 1990s (data not published, mentioned 
by Dr. Sosa-Estani), which may have benefited girls who are now 
mothers, who were still seroreactive but under the protective effect 
of the treatment18-22. As the antecedent of trypanocidal treatment 
was obtained based on the answers of the women included in the 
study, there could be a memory bias considering that trypanocidal 
was administered in these women during their early years.
In a broader view, a special dynamic of transmission would be 
operating in urban contexts and non-endemic areas, where infection 
is only mediated by CT and in which parasitic and immune factors 
would be shared and transmitted through generations, and may also 
be affected by environmental and social factors. All these factors 
continue under study and may allow us better comprehension of 
CT events and its manifestation at ecological level. 
This work contributes with observations in a large sample of 
contemporary population in an urban context of Argentina, which 
is the country with the highest absolute number of people with 
CD. These observations reinforce the hypotheses of parasitic and 
family characteristics leading to “cluster effect” and higher risk 
for CT, specifically observed in non-endemic and urban areas. 
Understanding CT in the new epidemiological scenario will allow 
us to reach a better approach to reduce its impact as a public health 
problem with global extent.
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